共 131 条
[1]
Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 3, pp. 209-249, (2021)
[2]
Anwanwan D., Singh S.K., Singh S., Saikam V., Singh R., Challenges in liver cancer and possible treatment approaches, Biochim Biophys Acta Rev Cancer, 1873, 1, (2020)
[3]
Vogel A., Meyer T., Sapisochin G., Salem R., Saborowski A., Hepatocellular carcinoma, Lancet, 400, pp. 1345-1362, (2022)
[4]
Yang J.D., Hainaut P., Gores G.J., Amadou A., Plymoth A., Roberts L.R., A global view of hepatocellular carcinoma: trends, risk, prevention and management, Nat Rev Gastroenterol Hepatol, 16, 10, (2019)
[5]
Kulik L., El-Serag H.B., Epidemiology and management of hepatocellular carcinoma, Gastroenterology, 156, 2, pp. 477-491.e1, (2019)
[6]
Shi J., Kantoff P.W., Wooster R., Farokhzad O.C., Cancer nanomedicine: progress, challenges and opportunities, Nat Rev Cancer, 17, 1, pp. 20-37, (2017)
[7]
Mohamed N., Hamad M., Hafez M., Wooley K., Elsabahy M., Nanomedicine in management of hepatocellular carcinoma: challenges and opportunities, Int J Cancer, 140, 7, pp. 1475-1484, (2017)
[8]
Baig B., Halim S.A., Farrukh A., Greish Y., Amin A., Current status of nanomaterial-based treatment for hepatocellular carcinoma, Biomed Pharmacother, 116, (2019)
[9]
Zhang W., Li M., Li X., Wang X., Liu Y., Yang J., Global trends and research status in ankylosing spondylitis clinical trials: a bibliometric analysis of the last 20 years, Front Immunol, (2024)
[10]
Amrapala A., Sabe M., Solmi M., Maes M., Neuropsychiatric disturbances in mild cognitive impairment: a scientometric analysis, Ageing Res Rev, 92, (2023)